These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9788686)

  • 41. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.
    Camarasa JM; Aliaga A; Fernández-Vozmediano JM; Fonseca E; Iglesias L; Tagarro I
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):77-86. PubMed ID: 11316966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of azelastine nasal spray and oral ebastine in treating seasonal allergic rhinitis.
    Conde Hernández DJ; Palma Aqilar JL; Delgado Romero J
    Curr Med Res Opin; 1995; 13(6):299-304. PubMed ID: 8829888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitis.
    Ciprandi G; Catrullo A; Tosca M; Cerqueti P; Mondino C; Passalacqua G; Canonica GW
    J Investig Allergol Clin Immunol; 1999; 9(1):35-8. PubMed ID: 10212855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
    Golden SJ; Craig TJ
    J Am Osteopath Assoc; 1999 Jul; 99(7 Suppl):S7-12. PubMed ID: 10478514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis.
    Sodhi PK; Pandey RM; Ratan SK
    Cornea; 2003 Apr; 22(3):210-3. PubMed ID: 12658084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W; Prenner B; Corren J; Wheeler W
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
    Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
    Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.
    Whitcup SM; Bradford R; Lue J; Schiffman RM; Abelson MB
    Clin Ther; 2004 Jan; 26(1):29-34. PubMed ID: 14996515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
    Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R;
    Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis.
    Abelson MB; Gomes P; Crampton HJ; Schiffman RM; Bradford RR; Whitcup SM
    Clin Ther; 2004 Jan; 26(1):35-47. PubMed ID: 14996516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis.
    Gastpar H; Nolte D; Aurich R; Brendt P; Enzmann H; Giesemann G; Kunkel G; Petzold U; Renz W; Schata M
    Allergy; 1994 Mar; 49(3):152-8. PubMed ID: 7911010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis.
    Storms WW; Pearlman DS; Chervinsky P; Grossman J; Halverson PC; Freitag JJ; Widlitz MD
    Ear Nose Throat J; 1994 Jun; 73(6):382-6, 390-4. PubMed ID: 8076537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study.
    Torkildsen GL; Ousler GW; Gomes P
    Clin Ther; 2008 Jul; 30(7):1264-71. PubMed ID: 18691985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
    Gehanno P; Deschamps E; Garay E; Baehre M; Garay RP
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(2):76-81. PubMed ID: 11244365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis.
    Orfeo V; Vardaro A; Lena P; Mensitieri I; Tracey M; De Marco R
    Eur J Ophthalmol; 2002; 12(4):262-6. PubMed ID: 12219994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.